Companies Dominating the Strand Displacement Amplification Landscape
- Lucira Health Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sherlock Biosciences
- Lucigen Corporation
- Bio-Rad Laboratories Inc
- G-Biosciences
- New England Bio-Labs
- Geno Technologies Inc
- Nippon Genetics Co, Ltd.
- Proteon Pharmaceuticals
- Hopan Fine Chemicals
Browse Key Market Insights with Data Illustration:
In the News
- To achieve its objective of making diagnostics simple to use, inexpensive, disposable, and environmentally friendly, Sherlock Biosciences purchased Sense Biodetection in February 2023. Products for SDA-based diagnostics are offered by Sense Biodetection.
- The FDA received an emergency use authorization request from Lucira Health, Inc. in January 2023 for the OTC use of their straightforward, at-home molecular COVID-19 and flu test, which makes use of SDA technology.
